Literature DB >> 8441954

The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.

A K Vine1, M M Samama.   

Abstract

The hemostatic mechanisms involve both an anticoagulant system to check the coagulation cascade and a fibrinolytic system to remove formed fibrin clots. Abnormalities of the hemostatic system or acquired abnormal hematological factors can produce a thrombophilic state which accounts for 15-28% of unexplained systemic vascular thrombosis in young patients. Similar abnormalities have recently been identified in some patients with retinal vascular occlusions. Screening of selected patients with retinal vascular occlusions may reveal additional ophthalmological patients with specific thrombotic syndromes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441954     DOI: 10.1016/0039-6257(93)90011-u

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  9 in total

1.  Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.

Authors:  A Glacet-Bernard; D Kuhn; A K Vine; H Oubraham; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

Authors:  F Y Demirci; R Küçükkaya; K Akarçay; N Kir; T Atamer; H Demirci; E Ongör
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

3.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

4.  Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.

Authors:  S Arséne; B Giraudeau; M-L Le Lez; P J Pisella; L Pourcelot; F Tranquart
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

5.  Genetic thrombophilia in patients with retinal vascular occlusion.

Authors:  K Greiner; D Peetz; A Winkgen; W Prellwitz; N Pfeiffer; G Hafner
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

6.  Is activated factor VII associated with retinal vein occlusion?

Authors:  S Kadayifçilar; D Ozatli; O Ozcebe; E C Sener
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

7.  Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis.

Authors:  H M Prince; P J Thurlow; R C Buchanan; K M Ibrahim; P J Neeson
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

8.  [Retinal vein branch occlusion and palsy of the N. abducens in protein S deficiency].

Authors:  H M Holak; N H Holak; S Holak; S A Holak; S Szymaniec
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

9.  Neutrophil/lymphocyte ratio and mean platelet volume in branch retinal vein occlusion.

Authors:  Esra Turkseven Kumral; Nursal Melda Yenerel; Nimet Yesim Ercalik; Serhat Imamoglu; Ece Turan Vural
Journal:  Saudi J Ophthalmol       Date:  2016-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.